U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209022

XHANCE (FLUTICASONE PROPIONATE)
0.093MG
Marketing Status: Prescription
Active Ingredient: FLUTICASONE PROPIONATE
Proprietary Name: XHANCE
Dosage Form; Route of Administration: SPRAY, METERED; NASAL
Strength: 0.093MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209022
Product Number: 001
Approval Date: Sep 18, 2017
Applicant Holder Full Name: OPTINOSE US INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top